New York City, NY -- (SBWIRE) -- 10/25/2013 -- StockMarketIntel.com issues a special report on the following stocks: Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY), Zynga Inc (NASDAQ:ZNGA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), FuelCell Energy Inc (NASDAQ:FCEL)
Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) gained 0.44%, trading on 1.12 million shares, to end the trade at $73.57. The stock changed hands in a range of $73.36 to $73.73, bringing its market capitalization to about $236.22 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $61.50 and was moved to the maximum level of $73.90. Nestle SA is a Switzerland-based holding company of the Nestle Group (the Group) and is principally engaged in the development and production of food and beverage. The Group manages its Food and Beverages business through three geographic zones (Zone Europe, Zone Americas and Zone Asia, Oceania and Africa) and globally for Nestle Waters, Nestle Nutrition and Other Food and Beverages (Others).
For How Long NSRGY Gloss will Attract Investors? Find out via this report
Zynga Inc (NASDAQ:ZNGA) declined -0.28%, to complete the trading session at $3.54, with a total volume of 47.19 million shares. The stock, on average, trades on a volume of 25.15 million shares. It floated in a range of $3.45 to $3.61. Its market capitalization now moved to about $2.84 billion. In the past 52 weeks, the share price has not declined below $2.09 and above $4.03. Zynga Inc. (Zynga) is the provider of social game services. The Company develops , market and operates online social games as live services played over the Internet and on social networking sites and mobile platforms. The Company's games are accessible on Facebook and other social networks, mobile platforms and Zynga.com.
Why Should Investors Buy ZNGA After the Recent Fall? Just Go Here and Find Out
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) recorded a gain of 9.48% and was in a range of $3.10-$3.42 before closing at $3.35. The stock completed the day with a total volume of 12.84 million shares, versus an average volume of 14.58 million shares. The share price hit its 52-week low of $2.62 and $24.59 was the best price. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.
Will ARIA Continue To Move Higher? Find Out Here
FuelCell Energy Inc (NASDAQ:FCEL) added 12.03% yesterday, bringing its market capitalization around $286.17 million. The share price, after opening at $1.35, made a high of $1.51 and hovered above $1.34 to end the day at $1.49. The total number of shares that changed hands during the session was 7.07 million shares, as compared to average trading volume of 1.52 million shares. FuelCell Energy, Inc. (FuelCell Energy) is a integrated fuel cell company. The Company designs, manufactures, sells, installs, operates and service ultra-clean, stationary fuel cell power plants for distributed baseload power generation.
Why Should Investors Buy FCEL After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)